ImportRefusal LogoImportRefusal

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

⚠️ Moderate Risk

FEI: 3005080039 • Shijiazhuang, Hebei • CHINA

FEI

FEI Number

3005080039

📍

Location

Shijiazhuang, Hebei

🇨🇳

Country

CHINA
🏢

Address

9 Fuqiang Road, Zhengding, , Shijiazhuang, Hebei, China

Moderate Risk

FDA Import Risk Assessment

36.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
3
Unique Violations
4/17/2015
Latest Refusal
4/23/2009
Earliest Refusal

Score Breakdown

Violation Severity
68.0×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
8.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1153×

DR QUALITY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to be represented as a drug the name of which is recognized in an official compendium and its strength appears to differ from or its quality or purity appear to fall below the standards set forth in such compendium.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
4/17/2015
61LCS08HEPARIN SODIUM (ANTI-COAGULANT)
3280FRNMFGREG
Southwest Import District Office (SWI-DO)
4/28/2009
61LDR08HEPARIN SODIUM (ANTI-COAGULANT)
115DR QUALITY
Los Angeles District Office (LOS-DO)
4/28/2009
61LDR08HEPARIN SODIUM (ANTI-COAGULANT)
115DR QUALITY
Los Angeles District Office (LOS-DO)
4/28/2009
61LDR08HEPARIN SODIUM (ANTI-COAGULANT)
115DR QUALITY
Los Angeles District Office (LOS-DO)
4/23/2009
61LDR08HEPARIN SODIUM (ANTI-COAGULANT)
27DRUG GMPS
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s FDA import refusal history?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (FEI: 3005080039) has 5 FDA import refusal record(s) in our database, spanning from 4/23/2009 to 4/17/2015.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s FEI number is 3005080039.

What types of violations has Hebei Changshan Biochemical Pharmaceutical Co., Ltd. received?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Hebei Changshan Biochemical Pharmaceutical Co., Ltd. come from?

All FDA import refusal data for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.